Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2024-05-09 Sale |
2024-05-17 8:00 pm |
LIGAND PHARMACEUTICALS INC | LGND | Gray Nancy Ryan Director |
934 | $83.2 | $77,713 | 5,633 (Direct) |
View |
| 2024-05-15 Sale |
2024-05-17 7:59 pm |
LIGAND PHARMACEUTICALS INC | LGND | Espinoza Octavio Chief Financial Officer |
13,293 | $86.26 | $1,146,704 | 65,530 (Direct) |
View |
| 2024-05-13 Sale |
2024-05-15 7:34 pm |
LIGAND PHARMACEUTICALS INC | LGND | Korenberg Matthew E President & Chief Operating |
17,598 | $84.99 | $1,495,740 | 86,263 (Direct) |
View |
| 2024-05-09 Sale |
2024-05-13 5:32 pm |
LIGAND PHARMACEUTICALS INC | LGND | Reardon Andrew Chief Legal Officer & |
10,000 | $83.04 | $830,449 | 85,149 (Direct) |
View |
| 2024-03-05 Sale |
2024-03-07 1:27 pm |
LIGAND PHARMACEUTICALS INC | LGND | Sabba Stephen L Director |
1,893 | $74.3 | $140,650 | 29,345 (Direct) |
View |
| 2024-02-28 Sale |
2024-02-29 6:50 pm |
LIGAND PHARMACEUTICALS INC | LGND | Espinoza Octavio Chief Financial Officer |
140 | $88.46 | $12,384 | 71,225 (Direct) |
View |
| 2023-09-22 Purchase |
2023-09-25 4:44 pm |
LIGAND PHARMACEUTICALS INC | LGND | Davis Todd C CHIEF EXECUTIVE OFFICER |
4,000 | $59.38 | $237,529 | 73,090 (Direct) |
View |
| 2023-05-16 Sale |
2023-05-18 5:18 pm |
LIGAND PHARMACEUTICALS INC | LGND | KOZARICH JOHN W Director |
4,444 | $77.2 | $343,081 | 38,488 (Direct) |
View |
| 2023-05-10 Sale |
2023-05-12 3:43 pm |
LIGAND PHARMACEUTICALS INC | LGND | Sabba Stephen L Director |
6,408 | $77.13 | $494,225 | 26,711 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2024-06-14 Option Award |
2024-06-18 9:26 pm |
N/A 2034-06-14 |
LIGAND PHARMACEUTICALS INC | LGND | Haas Jason Director |
6,696 | $0 | 10,841 (Direct) |
View |
| 2024-06-14 Option Award |
2024-06-18 9:26 pm |
N/A 2034-06-14 |
LIGAND PHARMACEUTICALS INC | LGND | Gray Nancy Ryan Director |
6,696 | $0 | 12,329 (Direct) |
View |
| 2024-06-14 Option Award |
2024-06-18 9:25 pm |
N/A 2034-06-14 |
LIGAND PHARMACEUTICALS INC | LGND | Aryeh Jason Director |
6,696 | $0 | 140,143 (Direct) |
View |
| 2024-05-17 Exercise |
2024-05-17 7:59 pm |
N/A 2030-10-01 |
LIGAND PHARMACEUTICALS INC | LGND | Espinoza Octavio Chief Financial Officer |
6,917 | $0 | 65,530 (Direct) |
View |
| 2024-05-17 Exercise |
2024-05-17 7:59 pm |
N/A N/A |
LIGAND PHARMACEUTICALS INC | LGND | Espinoza Octavio Chief Financial Officer |
5,022 | $52.84 | 65,530 (Direct) |
View |
| 2024-05-17 Exercise |
2024-05-17 7:59 pm |
N/A N/A |
LIGAND PHARMACEUTICALS INC | LGND | Espinoza Octavio Chief Financial Officer |
145 | $68.74 | 65,530 (Direct) |
View |
| 2024-05-17 Exercise |
2024-05-17 7:59 pm |
N/A N/A |
LIGAND PHARMACEUTICALS INC | LGND | Espinoza Octavio Chief Financial Officer |
206 | $57.22 | 65,530 (Direct) |
View |
| 2024-05-17 Exercise |
2024-05-17 7:59 pm |
N/A N/A |
LIGAND PHARMACEUTICALS INC | LGND | Espinoza Octavio Chief Financial Officer |
1,544 | $63.62 | 65,530 (Direct) |
View |
| 2024-05-09 Exercise |
2024-05-13 5:32 pm |
N/A 2032-08-01 |
LIGAND PHARMACEUTICALS INC | LGND | Reardon Andrew Chief Legal Officer & |
10,000 | $0 | 85,149 (Direct) |
View |
| 2024-05-09 Exercise |
2024-05-13 5:32 pm |
N/A N/A |
LIGAND PHARMACEUTICALS INC | LGND | Reardon Andrew Chief Legal Officer & |
10,000 | $52.27 | 85,149 (Direct) |
View |
| 2024-04-30 Exercise |
2024-05-02 6:07 pm |
N/A N/A |
LIGAND PHARMACEUTICALS INC | LGND | Aryeh Jason Director |
2,406 | $52.3 | 133,447 (Direct) |
View |
| 2024-04-30 Exercise |
2024-05-02 6:07 pm |
N/A 2025-04-24 |
LIGAND PHARMACEUTICALS INC | LGND | Aryeh Jason Director |
2,406 | $0 | 133,447 (Direct) |
View |
| 2024-04-24 Exercise |
2024-04-26 6:35 pm |
N/A N/A |
LIGAND PHARMACEUTICALS INC | LGND | KOZARICH JOHN W Director |
2,893 | $39.35 | 42,523 (Direct) |
View |
| 2024-04-24 Exercise |
2024-04-26 6:35 pm |
N/A 2024-06-04 |
LIGAND PHARMACEUTICALS INC | LGND | KOZARICH JOHN W Director |
2,893 | $0 | 42,523 (Direct) |
View |
| 2024-03-25 Exercise |
2024-03-27 5:47 pm |
N/A N/A |
LIGAND PHARMACEUTICALS INC | LGND | Davis Todd C Chief Executive Officer |
2,855 | $67.24 | 120,160 (Direct) |
View |
| 2024-03-25 Exercise |
2024-03-27 5:47 pm |
N/A 2032-06-10 |
LIGAND PHARMACEUTICALS INC | LGND | Davis Todd C Chief Executive Officer |
16,015 | $0 | 120,160 (Direct) |
View |
| 2024-03-25 Exercise |
2024-03-27 5:47 pm |
N/A N/A |
LIGAND PHARMACEUTICALS INC | LGND | Davis Todd C Chief Executive Officer |
3,556 | $66.19 | 120,160 (Direct) |
View |
| 2024-03-25 Exercise |
2024-03-27 5:47 pm |
N/A N/A |
LIGAND PHARMACEUTICALS INC | LGND | Davis Todd C Chief Executive Officer |
7,448 | $46.2 | 120,160 (Direct) |
View |
| 2024-03-25 Exercise |
2024-03-27 5:47 pm |
N/A N/A |
LIGAND PHARMACEUTICALS INC | LGND | Davis Todd C Chief Executive Officer |
2,156 | $68.51 | 120,160 (Direct) |
View |
| 2024-03-05 Exercise |
2024-03-07 1:27 pm |
N/A 2024-06-04 |
LIGAND PHARMACEUTICALS INC | LGND | Sabba Stephen L Director |
2,893 | $0 | 29,345 (Direct) |
View |
| 2024-03-05 Exercise |
2024-03-06 5:28 pm |
N/A N/A |
LIGAND PHARMACEUTICALS INC | LGND | Aryeh Jason Director |
2,893 | $39.35 | 131,041 (Direct) |
View |
| 2024-03-05 Exercise |
2024-03-06 5:28 pm |
N/A 2024-06-04 |
LIGAND PHARMACEUTICALS INC | LGND | Aryeh Jason Director |
2,893 | $0 | 131,041 (Direct) |
View |
| 2024-02-27 Option Award |
2024-02-29 6:50 pm |
N/A 2034-02-27 |
LIGAND PHARMACEUTICALS INC | LGND | Reardon Andrew CHIEF LEGAL OFFICER & |
36,480 | $0 | 51,477 (Direct) |
View |
| 2024-02-27 Option Award |
2024-02-29 6:50 pm |
N/A 2034-02-27 |
LIGAND PHARMACEUTICALS INC | LGND | Korenberg Matthew E PRESIDENT & CHIEF OPERATING |
72,960 | $0 | 162,405 (Direct) |
View |
| 2024-02-28 Exercise |
2024-02-29 6:50 pm |
N/A N/A |
LIGAND PHARMACEUTICALS INC | LGND | Espinoza Octavio Chief Financial Officer |
799 | $55.75 | 71,225 (Direct) |
View |
| 2024-02-28 Exercise |
2024-02-29 6:50 pm |
N/A 2030-02-13 |
LIGAND PHARMACEUTICALS INC | LGND | Espinoza Octavio Chief Financial Officer |
1,264 | $0 | 71,225 (Direct) |
View |
| 2024-02-28 Exercise |
2024-02-29 6:50 pm |
N/A N/A |
LIGAND PHARMACEUTICALS INC | LGND | Espinoza Octavio Chief Financial Officer |
325 | $58.49 | 71,225 (Direct) |
View |
| 2024-02-27 Option Award |
2024-02-29 6:50 pm |
N/A 2034-02-27 |
LIGAND PHARMACEUTICALS INC | LGND | Espinoza Octavio Chief Financial Officer |
36,480 | $0 | 71,225 (Direct) |
View |
| 2024-02-28 Exercise |
2024-02-29 6:50 pm |
N/A N/A |
LIGAND PHARMACEUTICALS INC | LGND | Espinoza Octavio Chief Financial Officer |
140 | $57.22 | 71,225 (Direct) |
View |
| 2024-02-27 Option Award |
2024-02-29 6:49 pm |
N/A 2034-02-27 |
LIGAND PHARMACEUTICALS INC | LGND | Davis Todd C CHIEF EXECUTIVE OFFICER |
164,159 | $0 | 235,868 (Direct) |
View |
| 2024-02-15 Tax Withholding |
2024-02-16 8:10 pm |
N/A N/A |
LIGAND PHARMACEUTICALS INC | LGND | Reardon Andrew CHIEF LEGAL OFFICER & |
593 | $74.65 | 14,997 (Direct) |
View |
| 2024-02-15 Tax Withholding |
2024-02-16 8:10 pm |
N/A N/A |
LIGAND PHARMACEUTICALS INC | LGND | Korenberg Matthew E PRESIDENT & CHIEF OPERATING |
4,778 | $74.65 | 89,445 (Direct) |
View |
| 2024-02-15 Tax Withholding |
2024-02-16 8:10 pm |
N/A N/A |
LIGAND PHARMACEUTICALS INC | LGND | Espinoza Octavio Chief Financial Officer |
1,479 | $74.65 | 21,423 (Direct) |
View |
| 2024-02-15 Tax Withholding |
2024-02-16 8:10 pm |
N/A N/A |
LIGAND PHARMACEUTICALS INC | LGND | Davis Todd C CHIEF EXECUTIVE OFFICER |
1,381 | $74.65 | 71,709 (Direct) |
View |
| 2023-12-29 Other |
2024-01-04 4:07 pm |
N/A N/A |
LIGAND PHARMACEUTICALS INC | LGND | Reardon Andrew CHIEF LEGAL OFFICER & |
179 | $60.71 | 15,769 (Direct) |
View |
| 2024-01-02 Tax Withholding |
2024-01-04 4:07 pm |
N/A N/A |
LIGAND PHARMACEUTICALS INC | LGND | Korenberg Matthew E PRESIDENT & CHIEF OPERATING |
2,917 | $72.31 | 94,223 (Direct) |
View |
| 2023-12-05 Tax Withholding |
2023-12-06 3:27 pm |
N/A N/A |
LIGAND PHARMACEUTICALS INC | LGND | Espinoza Octavio Chief Financial Officer |
1,269 | $59.61 | 22,902 (Direct) |
View |
| 2023-12-05 Tax Withholding |
2023-12-06 3:27 pm |
N/A N/A |
LIGAND PHARMACEUTICALS INC | LGND | Korenberg Matthew E PRESIDENT & CHIEF OPERATING |
1,984 | $59.61 | 97,140 (Direct) |
View |
| 2023-10-01 Tax Withholding |
2023-10-03 4:36 pm |
N/A N/A |
LIGAND PHARMACEUTICALS INC | LGND | Espinoza Octavio Chief Financial Officer |
346 | $59.92 | 24,171 (Direct) |
View |
| 2023-09-22 Option Award |
2023-09-26 4:41 pm |
N/A 2033-09-22 |
LIGAND PHARMACEUTICALS INC | LGND | Zimmermann Martine Director |
13,630 | $0 | 13,630 (Direct) |
View |
| 2023-08-10 Tax Withholding |
2023-08-14 4:20 pm |
N/A N/A |
LIGAND PHARMACEUTICALS INC | LGND | Reardon Andrew CHIEF LEGAL OFFICER & |
897 | $68.73 | 15,411 (Direct) |
View |
| 2023-06-30 Other |
2023-07-10 6:42 pm |
N/A N/A |
LIGAND PHARMACEUTICALS INC | LGND | Korenberg Matthew E PRESIDENT & CHIEF OPERATING |
376 | $56.78 | 99,500 (Direct) |
View |
| 2023-06-30 Other |
2023-07-10 6:42 pm |
N/A N/A |
LIGAND PHARMACEUTICALS INC | LGND | Espinoza Octavio Chief Financial Officer |
375 | $56.78 | 24,892 (Direct) |
View |
| 2023-06-09 Option Award |
2023-06-21 09:28 am |
N/A 2033-06-09 |
LIGAND PHARMACEUTICALS INC | LGND | Sabba Stephen L Director |
6,603 | $0 | 32,387 (Direct) |
View |
| 2023-06-09 Option Award |
2023-06-13 6:55 pm |
N/A 2033-06-09 |
LIGAND PHARMACEUTICALS INC | LGND | Gray Nancy Ryan Director |
6,603 | $0 | 12,028 (Direct) |
View |
| 2023-06-09 Option Award |
2023-06-13 6:55 pm |
N/A 2033-06-09 |
LIGAND PHARMACEUTICALS INC | LGND | LAMATTINA JOHN L Director |
6,603 | $0 | 33,724 (Direct) |
View |
| 2023-06-09 Option Award |
2023-06-13 6:54 pm |
N/A 2033-06-09 |
LIGAND PHARMACEUTICALS INC | LGND | KOZARICH JOHN W Director |
6,603 | $0 | 45,091 (Direct) |
View |
| 2023-06-09 Option Award |
2023-06-13 6:54 pm |
N/A 2033-06-09 |
LIGAND PHARMACEUTICALS INC | LGND | Aryeh Jason Director |
6,603 | $0 | 133,609 (Direct) |
View |
| 2023-06-09 Option Award |
2023-06-13 6:53 pm |
N/A 2033-06-09 |
LIGAND PHARMACEUTICALS INC | LGND | Haas Jason Director |
6,603 | $0 | 9,606 (Direct) |
View |
| 2023-06-09 Tax Withholding |
2023-06-13 6:52 pm |
N/A N/A |
LIGAND PHARMACEUTICALS INC | LGND | Davis Todd C CHIEF EXECUTIVE OFFICER |
420 | $73.76 | 69,090 (Direct) |
View |
| 2023-05-10 Exercise |
2023-05-12 3:43 pm |
N/A 2023-06-11 |
LIGAND PHARMACEUTICALS INC | LGND | Sabba Stephen L Director |
6,408 | $0 | 26,711 (Direct) |
View |